Resources with keywords: laboratory safety



Safe laboratory management of prions and proteopathic seeds
The Lancet Neurology

Mead, Simon et al.
The Lancet Neurology, Volume 20, Issue 12, 981

The UK’s Advisory Committee for Dangerous Pathogens convened a subgroup to revise guidance for safe working with prions and to consider whether any measures were needed for work with proteopathic seeds, involving experts from research laboratories for prion and other neurodegenerative diseases, infectious disease specialists, pathologists, veterinarians, and health and safety experts.

Laboratory biosafety guidance related to SARS-CoV-2 (COVID-19): Interim guidance, 11 March 2024 (NEW 4/3, Website, Regulatory)
WHO
11 March 2024

The latest update (11 March 2024) includes the following addition and revision:

  • depending on the local risk assessment, less stringent risk control measures for virus isolation and propagation of currently circulating strains;
  • biosafety aspects of waste management;
  • detailed considerations for transportation requirements; and
  • reference to the 4th edition Laboratory biosafety manual for GMPP (good microbiological practice and procedure) and to the Risk assessment monograph for the risk assessment template.
Laboratory biosafety guidance related to SARS-CoV-2 (COVID-19): Interim guidance, 11 March 2024 (NEW 5/10, Website, Regulatory)
World Health Organization (WHO)
11 March 2024

Provides interim guidance on laboratory biosafety related to the SARS-CoV-2 virus to laboratories and stakeholders involved in COVID-19 laboratory work. This also includes the packaging and shipment requirements for sending specimens to WHO reference laboratories providing confirmatory and other testing for COVID-19.

WHO Laboratory Biosafety Manual 4th edition (LBM4) (Website, Regulation/Guidance)
World Health Organization (WHO)

WHO Laboratory Biosafety Manual 4th edition (LBM4) are available in all UN official languages and Vietnamese:

LBM4 core doc https://iris.who.int/handle/10665/337956
Risk assessment monograph https://iris.who.int/handle/10665/337966
Lab design monograph https://iris.who.int/handle/10665/337960
Outbreak monograph https://iris.who.int/handle/10665/337959
Biosafety programme management monograph https://iris.who.int/handle/10665/337963
Biosafety cabinets monograph https://iris.who.int/handle/10665/337957
Decontamination monograph https://iris.who.int/handle/10665/374887
PPE monograph https://iris.who.int/handle/10665/337961

Information For Laboratory Personnel
CDC

Includes aboratory biosafety guidelines, testing, reporting procedures, use of PPE, specimen collection, packaging and transport, etc.

Candida auris: A drug-resistant fungus that spreads in healthcare facilities - A CDC message to laboratory staff
CDC
Monkeypox Virus Infection Resulting from an Occupational Needlestick — Florida, 2022
CDC/MMWR
21 October 2022

Mendoza R, Petras JK, Jenkins P, et al.

ACTIVIDADES CLAVES PARA LA CONTENCIÓN DE POLIOVIRUS, RESOLUCION WHA71.16
WHO/PAHO
Consideraciones en el marco de la contención de los poliovirus en las Américas, GAPIII- Regional
WHO/PAHO
Orientación para minimizar el riesgo en las instalaciones que obtienen, manipulan o almacenan materiales potencialmente infecciosos de poliovirus
WHO/PAHO
Go to Top